) based devices exhibit key features suitable for ocular surface drug delivery: structural adaptability, controlled release kinetics, and compatibility with biologically active macromolecules. These platforms may represent a promising tool for targeted and prolonged drug administration in ocular diseases requiring frequent and localized treatment.
No takes yet. Share an insight, caveat, or question.
Astolfi et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: